| Literature DB >> 24833960 |
Kanichi Kusano1, Seiji Hobo2, Hirotaka Ode2, Yuhiro Ishikawa1.
Abstract
Cytology of tracheal aspirates, tracheal endoscopic and blood tests were carried out to 86 Thoroughbred racehorses presenting coughs or poor performance which were suspected to have lower respiratory tract disease (LRTD) to assess the conditions of the disorders. Racehorses were classified into coughing (66 horses) and non-coughing (20 horses) groups based on clinical symptoms. Nine Thoroughbred racehorses without respiratory abnormality were used as controls. Assessment of grades of airway mucus, cytology of tracheal aspirates and serum amyloid A (SAA), fibrinogen (Fbg) and pulmonary surfactant protein D (SP-D) measurements were performed. Relationships between age, gender and racing careers were also investigated to understand the characteristics of LRTD in racehorses. Mean age was significantly higher in non-coughing group compared to coughing group. Existence of racing career and number of starts were significantly greater in non-coughing group compared to coughing group. On the other hand, grades of airway mucus were significantly higher in coughing group compared to control group. Percentages of neutrophils in tracheal aspirates were significantly higher in coughing group compared to non-coughing and control groups. SAA, Fbg and SP-D were higher in coughing group compared to non-coughing and control groups indicating that condition of coughing group is in the acute phase. Positive rate of inflammatory airway disease was significantly higher in coughing and non-coughing groups compared to control group. It was concluded that carrying out comprehensive evaluation including investigation on SAA, Fbg and SP-D analysis with airway assessment to Thoroughbred racehorses which were suspected to have LRTD are useful procedure to understand the pathological condition which aid to initiate appropriate treatment, prognosis judgment or to advise trainers to consider altering training regimen.Entities:
Keywords: Thoroughbred racehorse; cough; inflammatory airway disease; lower respiratory tract; poor performance
Year: 2009 PMID: 24833960 PMCID: PMC4013951 DOI: 10.1294/jes.19.97
Source DB: PubMed Journal: J Equine Sci ISSN: 1340-3516
Gender and age of studied Thoroughbred racehorses
| Group | Gender | Age | |||
|---|---|---|---|---|---|
| Male | Female | Total | Ratio | (Years old) | |
| non-coughing | 13 | 7 | 20 | 1.86 | 3.3 ± 0.9a (2–5) |
| coughing | 37 | 29 | 66 | 1.28 | 2.6 ± 1.0a (2–7) |
| control | 5 | 4 | 9 | 1.25 | 2.9 ± 1.8 (2–7) |
| Total | 55 | 40 | 95 | — | — |
Gender: Geldings are included in male. Ratio: Ratio of male to female. a Significant differences among same alphabet (P<0.01). Age is indicated as mean ± SD (range).
Racing careers of studied Thoroughbred racehorses
| Goup | Racing career | Number of starts | Days from the latest start | Days to nearest start | |
|---|---|---|---|---|---|
| More than one start (%) | None (%) | (Starts) | (Days) | (Days) | |
| non-coughing | 65.0a | 35.0b | 6.7 ± 8.0c* | 44.5 ± 58.7 | 144.3 ± 77.4 |
| coughing | 34.8a | 65.2b | 2.7 ± 6.0c | 40.1 ± 76.2 | 91.4 ± 34.6 |
Racing career: Existence or nonexistence of racing career prior to examination. Number of starts: Numbers of starts prior to examination. Days from the latest start: Mean days from the latest start prior to examination. Days to nearest start: Days from examination to nearest start after examination. a,b Significant differences among same alphabet (P<0.01). c Significant differences among same alphabet (P<0.05). *Data are indicated as mean ± SD.
Relationship of the prevalence of TM to each group
| Group | Total | Grade | P-value | |||
|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | (χ2 test) | ||
| non-coughing | 20 | 4 | 10 | 4 | 2 | |
| coughing | 66 | 5 | 22 | 23 | 16 | a |
| control | 9 | 4 | 4 | 1 | 0 | a |
Data are expressed number of horses. a Significant differences among same alphabet (P<0.01).
Results of tracheal aspirates and blood tests of studied Thoroughbred racehorses
| Group | Tracheal aspirates | SAA
(μg/m | Fbg
(mg/d | SP-D
(ng/m | |
|---|---|---|---|---|---|
| Neutrophils (%) | IAD positive (%) | ||||
| non-coughing | 31.0 ± 16.5a * | 60.0c | 0.5 ± 0.6 | 255.3 ± 68.1 | 0.6 ± 2.4 |
| coughing | 52.1 ± 25.3a,b | 91.8d | 52.9 ± 156.3 | 311.7 ± 123.2 | 4.9 ± 12.3 |
| control | 12.3 ± 2.9b | 0.0c,d | 0.2 ± 0.4 | 254.1 ± 20.0 | 0.0 ± 0.0 |
a, b, c, d Significant differences among same alphabet (P<0.01). *Data are indicated as mean ± SD.